Clinical trials

  • sulodexide
  • ALE.P02 for Squamous non-small cell lung carcinoma (advanced/metastatic) | Head and neck squamous cell carcinoma | Esophageal squamous cell carcinoma | Cutaneous squamous cell carcinoma
  • [N-{(4R)-4-CARBOXY-ΚO-4-[4,7,10-TRIS(CARBOXY-Κ3O4,O7,O10-METHYL)-1,4,7,10-TETRAAZACYCLODODECAN-1-YL-Κ4N1,N4,N7,N10]BUTANOYL}-3-IODO-D-TYROSYL-D-PHENYLALANYL-N6-(8-{N2-[(L-GLUTAMIC ACID-N-YL)CARBONYL]-L-LYSIN-N6-YL}-8-OXOOCTANOYL)-D-LYSINATO(3−)](177LU)LUTETIUM for Metastatic castration-resistant prostate cancer
  • Clinical trial in Non-Hodgkin lymphoma|Chronic lymphocytic leukemia
  • BGB-11417 for Mature B-cell malignancies
  • Idarubicin hydrochloride for Hepatocellular carcinoma
  • Acetylsalicylic acid for Female infertility
  • Efgartigimod alfa for Primary immune thrombocytopenia (ITP)
  • OXYTOCIN for Borderline Personality Disorder
  • ANTI-(INSULIN RECEPTOR) HUMAN MONOCLONAL ANTIBODY for Tumor-associated hyperinsulinism|Insulinoma
  • ANHYDROUS BENZOYL PEROXIDE for Cutibacterium acnes infection | Shoulder prosthetic joint infection
  • Avelumab for Gestational trophoblastic neoplasia (low-risk)